Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oncolytic Virus Immunotherapy Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Engineering Oncolytic Viruses
1.2.3 Wild-Type Oncolytic Viruses
1.3 Market by Application
1.3.1 Global Oncolytic Virus Immunotherapy Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oncolytic Virus Immunotherapy Market Perspective (2018-2033)
2.2 Oncolytic Virus Immunotherapy Growth Trends by Region
2.2.1 Global Oncolytic Virus Immunotherapy Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Oncolytic Virus Immunotherapy Historic Market Size by Region (2018-2023)
2.2.3 Oncolytic Virus Immunotherapy Forecasted Market Size by Region (2024-2033)
2.3 Oncolytic Virus Immunotherapy Market Dynamics
2.3.1 Oncolytic Virus Immunotherapy Industry Trends
2.3.2 Oncolytic Virus Immunotherapy Market Drivers
2.3.3 Oncolytic Virus Immunotherapy Market Challenges
2.3.4 Oncolytic Virus Immunotherapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oncolytic Virus Immunotherapy Players by Revenue
3.1.1 Global Top Oncolytic Virus Immunotherapy Players by Revenue (2018-2023)
3.1.2 Global Oncolytic Virus Immunotherapy Revenue Market Share by Players (2018-2023)
3.2 Global Oncolytic Virus Immunotherapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Oncolytic Virus Immunotherapy Revenue
3.4 Global Oncolytic Virus Immunotherapy Market Concentration Ratio
3.4.1 Global Oncolytic Virus Immunotherapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oncolytic Virus Immunotherapy Revenue in 2022
3.5 Oncolytic Virus Immunotherapy Key Players Head office and Area Served
3.6 Key Players Oncolytic Virus Immunotherapy Product Solution and Service
3.7 Date of Enter into Oncolytic Virus Immunotherapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Oncolytic Virus Immunotherapy Breakdown Data by Type
4.1 Global Oncolytic Virus Immunotherapy Historic Market Size by Type (2018-2023)
4.2 Global Oncolytic Virus Immunotherapy Forecasted Market Size by Type (2024-2033)
5 Oncolytic Virus Immunotherapy Breakdown Data by Application
5.1 Global Oncolytic Virus Immunotherapy Historic Market Size by Application (2018-2023)
5.2 Global Oncolytic Virus Immunotherapy Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Oncolytic Virus Immunotherapy Market Size (2018-2033)
6.2 North America Oncolytic Virus Immunotherapy Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Oncolytic Virus Immunotherapy Market Size by Country (2018-2023)
6.4 North America Oncolytic Virus Immunotherapy Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Oncolytic Virus Immunotherapy Market Size (2018-2033)
7.2 Europe Oncolytic Virus Immunotherapy Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Oncolytic Virus Immunotherapy Market Size by Country (2018-2023)
7.4 Europe Oncolytic Virus Immunotherapy Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Oncolytic Virus Immunotherapy Market Size (2018-2033)
8.2 Asia-Pacific Oncolytic Virus Immunotherapy Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Oncolytic Virus Immunotherapy Market Size by Region (2018-2023)
8.4 Asia-Pacific Oncolytic Virus Immunotherapy Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Oncolytic Virus Immunotherapy Market Size (2018-2033)
9.2 Latin America Oncolytic Virus Immunotherapy Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Oncolytic Virus Immunotherapy Market Size by Country (2018-2023)
9.4 Latin America Oncolytic Virus Immunotherapy Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oncolytic Virus Immunotherapy Market Size (2018-2033)
10.2 Middle East & Africa Oncolytic Virus Immunotherapy Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Oncolytic Virus Immunotherapy Market Size by Country (2018-2023)
10.4 Middle East & Africa Oncolytic Virus Immunotherapy Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Detail
11.1.2 Merck Business Overview
11.1.3 Merck Oncolytic Virus Immunotherapy Introduction
11.1.4 Merck Revenue in Oncolytic Virus Immunotherapy Business (2018-2023)
11.1.5 Merck Recent Development
11.2 Amgen
11.2.1 Amgen Company Detail
11.2.2 Amgen Business Overview
11.2.3 Amgen Oncolytic Virus Immunotherapy Introduction
11.2.4 Amgen Revenue in Oncolytic Virus Immunotherapy Business (2018-2023)
11.2.5 Amgen Recent Development
11.3 TILT Biotherapeutics
11.3.1 TILT Biotherapeutics Company Detail
11.3.2 TILT Biotherapeutics Business Overview
11.3.3 TILT Biotherapeutics Oncolytic Virus Immunotherapy Introduction
11.3.4 TILT Biotherapeutics Revenue in Oncolytic Virus Immunotherapy Business (2018-2023)
11.3.5 TILT Biotherapeutics Recent Development
11.4 Oncorus
11.4.1 Oncorus Company Detail
11.4.2 Oncorus Business Overview
11.4.3 Oncorus Oncolytic Virus Immunotherapy Introduction
11.4.4 Oncorus Revenue in Oncolytic Virus Immunotherapy Business (2018-2023)
11.4.5 Oncorus Recent Development
11.5 Sorrento Therapeutics
11.5.1 Sorrento Therapeutics Company Detail
11.5.2 Sorrento Therapeutics Business Overview
11.5.3 Sorrento Therapeutics Oncolytic Virus Immunotherapy Introduction
11.5.4 Sorrento Therapeutics Revenue in Oncolytic Virus Immunotherapy Business (2018-2023)
11.5.5 Sorrento Therapeutics Recent Development
11.6 Shanghai Sunway Biotech
11.6.1 Shanghai Sunway Biotech Company Detail
11.6.2 Shanghai Sunway Biotech Business Overview
11.6.3 Shanghai Sunway Biotech Oncolytic Virus Immunotherapy Introduction
11.6.4 Shanghai Sunway Biotech Revenue in Oncolytic Virus Immunotherapy Business (2018-2023)
11.6.5 Shanghai Sunway Biotech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Oncolytic Virus Immunotherapy Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Engineering Oncolytic Viruses
Table 3. Key Players of Wild-Type Oncolytic Viruses
Table 4. Global Oncolytic Virus Immunotherapy Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global Oncolytic Virus Immunotherapy Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Oncolytic Virus Immunotherapy Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Oncolytic Virus Immunotherapy Market Share by Region (2018-2023)
Table 8. Global Oncolytic Virus Immunotherapy Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Oncolytic Virus Immunotherapy Market Share by Region (2024-2033)
Table 10. Oncolytic Virus Immunotherapy Market Trends
Table 11. Oncolytic Virus Immunotherapy Market Drivers
Table 12. Oncolytic Virus Immunotherapy Market Challenges
Table 13. Oncolytic Virus Immunotherapy Market Restraints
Table 14. Global Oncolytic Virus Immunotherapy Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Oncolytic Virus Immunotherapy Market Share by Players (2018-2023)
Table 16. Global Top Oncolytic Virus Immunotherapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncolytic Virus Immunotherapy as of 2022)
Table 17. Ranking of Global Top Oncolytic Virus Immunotherapy Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Oncolytic Virus Immunotherapy Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Oncolytic Virus Immunotherapy Product Solution and Service
Table 21. Date of Enter into Oncolytic Virus Immunotherapy Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Oncolytic Virus Immunotherapy Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Oncolytic Virus Immunotherapy Revenue Market Share by Type (2018-2023)
Table 25. Global Oncolytic Virus Immunotherapy Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Oncolytic Virus Immunotherapy Revenue Market Share by Type (2024-2033)
Table 27. Global Oncolytic Virus Immunotherapy Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Oncolytic Virus Immunotherapy Revenue Market Share by Application (2018-2023)
Table 29. Global Oncolytic Virus Immunotherapy Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Oncolytic Virus Immunotherapy Revenue Market Share by Application (2024-2033)
Table 31. North America Oncolytic Virus Immunotherapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America Oncolytic Virus Immunotherapy Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Oncolytic Virus Immunotherapy Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe Oncolytic Virus Immunotherapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe Oncolytic Virus Immunotherapy Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Oncolytic Virus Immunotherapy Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific Oncolytic Virus Immunotherapy Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific Oncolytic Virus Immunotherapy Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Oncolytic Virus Immunotherapy Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America Oncolytic Virus Immunotherapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America Oncolytic Virus Immunotherapy Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Oncolytic Virus Immunotherapy Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa Oncolytic Virus Immunotherapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa Oncolytic Virus Immunotherapy Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Oncolytic Virus Immunotherapy Market Size by Country (2024-2033) & (US$ Million)
Table 46. Merck Company Detail
Table 47. Merck Business Overview
Table 48. Merck Oncolytic Virus Immunotherapy Product
Table 49. Merck Revenue in Oncolytic Virus Immunotherapy Business (2018-2023) & (US$ Million)
Table 50. Merck Recent Development
Table 51. Amgen Company Detail
Table 52. Amgen Business Overview
Table 53. Amgen Oncolytic Virus Immunotherapy Product
Table 54. Amgen Revenue in Oncolytic Virus Immunotherapy Business (2018-2023) & (US$ Million)
Table 55. Amgen Recent Development
Table 56. TILT Biotherapeutics Company Detail
Table 57. TILT Biotherapeutics Business Overview
Table 58. TILT Biotherapeutics Oncolytic Virus Immunotherapy Product
Table 59. TILT Biotherapeutics Revenue in Oncolytic Virus Immunotherapy Business (2018-2023) & (US$ Million)
Table 60. TILT Biotherapeutics Recent Development
Table 61. Oncorus Company Detail
Table 62. Oncorus Business Overview
Table 63. Oncorus Oncolytic Virus Immunotherapy Product
Table 64. Oncorus Revenue in Oncolytic Virus Immunotherapy Business (2018-2023) & (US$ Million)
Table 65. Oncorus Recent Development
Table 66. Sorrento Therapeutics Company Detail
Table 67. Sorrento Therapeutics Business Overview
Table 68. Sorrento Therapeutics Oncolytic Virus Immunotherapy Product
Table 69. Sorrento Therapeutics Revenue in Oncolytic Virus Immunotherapy Business (2018-2023) & (US$ Million)
Table 70. Sorrento Therapeutics Recent Development
Table 71. Shanghai Sunway Biotech Company Detail
Table 72. Shanghai Sunway Biotech Business Overview
Table 73. Shanghai Sunway Biotech Oncolytic Virus Immunotherapy Product
Table 74. Shanghai Sunway Biotech Revenue in Oncolytic Virus Immunotherapy Business (2018-2023) & (US$ Million)
Table 75. Shanghai Sunway Biotech Recent Development
Table 76. Research Programs/Design for This Report
Table 77. Key Data Information from Secondary Sources
Table 78. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Oncolytic Virus Immunotherapy Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Oncolytic Virus Immunotherapy Market Share by Type: 2022 VS 2033
Figure 3. Engineering Oncolytic Viruses Features
Figure 4. Wild-Type Oncolytic Viruses Features
Figure 5. Global Oncolytic Virus Immunotherapy Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global Oncolytic Virus Immunotherapy Market Share by Application: 2022 VS 2033
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Ambulatory Surgical Centers Case Studies
Figure 10. Oncolytic Virus Immunotherapy Report Years Considered
Figure 11. Global Oncolytic Virus Immunotherapy Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 12. Global Oncolytic Virus Immunotherapy Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 13. Global Oncolytic Virus Immunotherapy Market Share by Region: 2022 VS 2033
Figure 14. Global Oncolytic Virus Immunotherapy Market Share by Players in 2022
Figure 15. Global Top Oncolytic Virus Immunotherapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncolytic Virus Immunotherapy as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Oncolytic Virus Immunotherapy Revenue in 2022
Figure 17. North America Oncolytic Virus Immunotherapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 18. North America Oncolytic Virus Immunotherapy Market Share by Country (2018-2033)
Figure 19. United States Oncolytic Virus Immunotherapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. Canada Oncolytic Virus Immunotherapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Europe Oncolytic Virus Immunotherapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Oncolytic Virus Immunotherapy Market Share by Country (2018-2033)
Figure 23. Germany Oncolytic Virus Immunotherapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. France Oncolytic Virus Immunotherapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. U.K. Oncolytic Virus Immunotherapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Italy Oncolytic Virus Immunotherapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Russia Oncolytic Virus Immunotherapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Nordic Countries Oncolytic Virus Immunotherapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Asia-Pacific Oncolytic Virus Immunotherapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Oncolytic Virus Immunotherapy Market Share by Region (2018-2033)
Figure 31. China Oncolytic Virus Immunotherapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Japan Oncolytic Virus Immunotherapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. South Korea Oncolytic Virus Immunotherapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Southeast Asia Oncolytic Virus Immunotherapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. India Oncolytic Virus Immunotherapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Australia Oncolytic Virus Immunotherapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Latin America Oncolytic Virus Immunotherapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Oncolytic Virus Immunotherapy Market Share by Country (2018-2033)
Figure 39. Mexico Oncolytic Virus Immunotherapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Brazil Oncolytic Virus Immunotherapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Middle East & Africa Oncolytic Virus Immunotherapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Oncolytic Virus Immunotherapy Market Share by Country (2018-2033)
Figure 43. Turkey Oncolytic Virus Immunotherapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Saudi Arabia Oncolytic Virus Immunotherapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Merck Revenue Growth Rate in Oncolytic Virus Immunotherapy Business (2018-2023)
Figure 46. Amgen Revenue Growth Rate in Oncolytic Virus Immunotherapy Business (2018-2023)
Figure 47. TILT Biotherapeutics Revenue Growth Rate in Oncolytic Virus Immunotherapy Business (2018-2023)
Figure 48. Oncorus Revenue Growth Rate in Oncolytic Virus Immunotherapy Business (2018-2023)
Figure 49. Sorrento Therapeutics Revenue Growth Rate in Oncolytic Virus Immunotherapy Business (2018-2023)
Figure 50. Shanghai Sunway Biotech Revenue Growth Rate in Oncolytic Virus Immunotherapy Business (2018-2023)
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed